Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · DEFA14A

Lifevantage Corporation

LFVNNASDAQEQUITYCurrent

SEC Filing

Filed Sep 18, 2026Accepted Sep 18, 2026, 4:10 PM EDTCIK 849146Accession 0001193125-26-395535
Share

Company context

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics - the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the MindBody GLP-1 SystemÒ, the newest comprehensive gut activator from LoveBiome P84, the Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic and hydration energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Current securities

Recent company filings

  1. ARS filingSep 18, 2026
  2. DEF 14A filingSep 18, 2026
  3. 4 filingSep 17, 2026
  4. Results of Operations and Financial ConditionAug 27, 2026
  5. 10-K filingAug 27, 2026

As-filed source

Primary evidence